methylprednisolone hemisuccinate has been researched along with Cancer of Paranasal Sinus in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balayre, S; Dighiero, P; Gicquel, JJ; Mercie, M | 1 |
1 other study(ies) available for methylprednisolone hemisuccinate and Cancer of Paranasal Sinus
| Article | Year |
|---|---|
[Orbital extension of sinus plasmacytoma secondarily transforming into multiple myeloma: a case study].
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Dexamethasone; Diplopia; Doxorubicin; Ethmoid Sinus; Etoposide; Exophthalmos; Humans; Male; Maxillary Sinus; Maxillary Sinus Neoplasms; Methylprednisolone Hemisuccinate; Multiple Myeloma; Orbit; Orbital Neoplasms; Paranasal Sinus Neoplasms; Plasmacytoma; Tomography, X-Ray Computed; Treatment Outcome; Vincristine; Visual Acuity | 2004 |